From the MD Magazine news item: The US Food and Drug Administration (FDA) has released a warning for health care professionals to take caution before prescribing the bacterial antibiotic clarithromycin (Biaxin, AbbVie) to patients with heart disease, as it reportedly raises the risk of heart […]